Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00797797 · ClinicalTrials.gov registry record · Phase 3
Study of Milnacipran Added to Pregabalin for Treatment of Fibromyalgia
A Phase 3 study, sponsored by Forest Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 364
- Enrollment target
NCT00797797 is a Phase 3 study that has completed, run by Forest Laboratories. The registered enrollment target is 364 participants.
The verdict
NCT00797797, a Phase 3 study, has completed, sponsored by Forest Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 364 participants
- Enrollment target
Study Summary
To evaluate the safety, tolerability, and efficacy of milnacipran when taken with another drug called pregabalin in people with fibromyalgia.
Interventions
- DRUG No Treatment Added
- DRUG Milnacipran Added
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 364 participants |
| Start Date | 2008-11 |
| Est. Completion | 2010-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00797797
The ClinicalTrials.gov registry entry for NCT00797797 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 364 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Forest Laboratories, which has 145 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which No Treatment Added is the first listed.
NCT00797797 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00797797 about?
NCT00797797 is a clinical study titled "Study of Milnacipran Added to Pregabalin for Treatment of Fibromyalgia". To evaluate the safety, tolerability, and efficacy of milnacipran when taken with another drug called pregabalin in people with fibromyalgia.
What is the current status of trial NCT00797797?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 364 participants. The study started on 2008-11. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00797797?
The interventions under investigation include: No Treatment Added (DRUG), Milnacipran Added (DRUG).
Who is sponsoring clinical trial NCT00797797?
This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.